Invent Medic Sweden AB: Year-End Report 2019
The Board of Directors and the CEO reports the following for the fiscal year 2019. Unless otherwise stated, all amounts are reported in integers SEK (SEK). Data in parentheses refer to the previous year.Strong fourth quarter with the first order for Efemia from a Swedish healthcare regionand distribution agreements for Norway, the Netherlands and Belgium. TWELVE MONTHS (January–December 2019)∞ The company’s sales amounted to 620 (41) KSEK.∞ Other operating income amounted to 0 (17) KSEK.∞ Work capitalised by the company for its own use amounted to 0 (427) KSEK.∞ Operating costs